Login / Signup

Long-term safety and efficacy of upadacitinib versus adalimumab in patients with rheumatoid arthritis: 5-year data from the phase 3, randomised SELECT-COMPARE study.

Roy M FleischmannJerzy SwierkotSara K PennPatrick DurezLouis BessetteXianwei BuNasser KhanYihan LiCharles G PeterfyYoshiya TanakaEduardo Mysler
Published in: RMD open (2024)
NCT02629159.
Keyphrases
  • clinical trial
  • rheumatoid arthritis
  • open label
  • electronic health record
  • randomized controlled trial
  • double blind
  • juvenile idiopathic arthritis
  • placebo controlled
  • data analysis
  • hidradenitis suppurativa